Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...

In the research, mice were fed a high-fat diet were injected with the compound AP39, which delivers hydrogen sulfide direct to mitochondria in cells The research concluded that the treatment ...

Newly released data shows that the U.S. may have reached peak obesity in 2020 — and the timing unsurprisingly coincides with ...

The average workplace health insurance plan costs more than $25,000 amid rising prices and expensive weight-loss drugs such ...

A new national survey shows that, despite intense marketing, most Americans do not want the new weight-loss injectables, such ...

One creator suggests that lemon balm helps with stress, insomnia, alertness, and that it’s been found to potentially help ...

A woman who had life-changing results on a popular weight loss drug struggled ... a promising new weight-loss medication. Over the course of the 18-month trial, from 2020 to 2021, she lost more ...

says her life changed when she joined a clinical trial for a promising new weight-loss medication. Over the course of the 18-month trial, from 2020 to 2021, she lost more than 200 pounds — more ...

A Swiss pharmaceutical company hoping to cash in on the weight loss drug trend is having its dreams dashed amid new results showing that the drugs cause a broad majority of patients to yak.

FROM LOS ANGELES to London, weight-loss drugs such ... more than 90% since June 2021, with investors worried about growth prospects. In time the drugs may even lure new readers.